Taylor Morrison Home Corporation (TMHC) — Fair Value Analysis

Base-case fair value (P50): $65.87 · Current price: $72.45 · Verdict: Fairly Valued

The Verdict on TMHC

TAYLOR MORRISON HOME CORP (TMHC) appears Fairly Valued at its current market price of $72.45, according to our Monte Carlo simulations. Our median fair value (P50) assessment for TMHC stands at $65.87, indicating a projected -9.1% against the current trading price. This narrow spread suggests that the market's present valuation closely aligns with the intrinsic value derived from thousands of forward-looking financial scenarios. While some equity models might point to a clear over or undervaluation, our comprehensive probabilistic analysis positions TMHC comfortably within its fair value range, implying limited immediate arbitrage opportunities based solely on a median projection.

How TMHC stacks up against peers

TMHC's operational and financial health is categorized as average when compared to its sector peers. This average quality tier supports the Fairly Valued verdict, as it doesn't suggest a company with outstanding competitive advantages warranting a significant premium, nor does it indicate severe underlying issues that would lead to a substantial discount. The $72.45 reflects a market perception consistent with a company exhibiting standard sector performance and a balanced risk profile. An average quality tier, coupled with a median fair value of $65.87, reinforces the view that TMHC is priced appropriately given its fundamental standing.

What this means for investors

For investors considering TMHC, the Fairly Valued verdict at $72.45 implies that the current price already incorporates much of the known fundamental information. The -9.1% differential from our $65.87 fair value suggests that while there isn't a compelling discount, the company is not trading at an excessive premium either. Potential upside scenarios and downside scenarios exist, but the median Monte Carlo outcome indicates a neutral outlook at this time. To understand the full probabilistic distribution of TMHC’s fair value and track how it evolves, sign up for a free FairCurve account and access our detailed bear and bull case targets.